NOVARTIS AG (NVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5B 10B 15B Q2 '17: 12.2B Q2 '18: 11.4B Q2 '19: 11.8B Q2 '20: 11.3B Q2 '21: 13B Q2 '22: 12.8B Q2 '23: 11.4B Q2 '24: 12.5B Q2 '25: 14.1B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Gross Profit Quarterly

0 4B 8B 12B Q2 '17: 8.2B Q2 '18: 8.1B Q2 '19: 8.6B Q2 '20: 8.2B Q2 '21: 9.4B Q2 '22: 9.3B Q2 '23: 8.4B Q2 '24: 9.7B Q2 '25: 11.5B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Operating Income Quarterly

0 2B 4B 6B Q2 '17: 2.3B Q2 '18: 2.4B Q2 '19: 2.7B Q2 '20: 2.4B Q2 '21: 3.5B Q2 '22: 2.2B Q2 '23: 2.8B Q2 '24: 4B Q2 '25: 4.9B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Net Income Quarterly

0 3B 6B 9B Q2 '17: 2B Q2 '18: 7.8B Q2 '19: 6.8B Q2 '20: 1.9B Q2 '21: 2.9B Q2 '22: 1.7B Q2 '23: 2.3B Q2 '24: 3.2B Q2 '25: 4B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Cost of Revenue Quarterly

0 1.5B 3B 4.5B Q2 '17: 4.3B Q2 '18: 3.6B Q2 '19: 3.4B Q2 '20: 3.4B Q2 '21: 3.9B Q2 '22: 3.8B Q2 '23: 3.3B Q2 '24: 3.2B Q2 '25: 3.3B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Operating Cash Flow Quarterly

0 2.5B 5B 7.5B Q2 '17: 3.6B Q2 '18: 3.9B Q2 '19: 3.1B Q2 '20: 4B Q2 '21: 4.1B Q2 '22: 3.8B Q2 '23: 3.6B Q2 '24: 4.9B Q2 '25: 6.7B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Free Cash Flow Quarterly

0 2.5B 5B 7.5B Q2 '17: 3.2B Q2 '18: 3.7B Q2 '19: 2.8B Q2 '20: 3.7B Q2 '21: 3.8B Q2 '22: 3.5B Q2 '23: 3.4B Q2 '24: 4.6B Q2 '25: 6.3B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.